ArticleCancers2020

Circulating IL-13 Is Associated with De Novo Development of HCC in HCV-Infected Patients Responding to Direct-Acting Antivirals.

Zuzana Macek Jílková et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.